the authors conclude sclerosing adenosis represents an independent risk factor for subsequent invasive breast cancer apart from its association with alh , and the risk ( excluding patients with coexistent atypical hyperplasia ) is in the range of 1.7 , times thereby justifying inclusion of sclerosing adenosis as a component of a group of histopathologically defined lesions termed `` '' proliferative breast disease without atypia '' '' which implies a relative cancer risk of 1.5 to 2.0 .
C0333977
atypical hyperplasia
C0741302
atypi